ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Position in LIVN — LivaNova PLC

CIK 1164508 BOSTON, MA

Position in LIVN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$18,327,144

+$12,212,348 QoQ

Shares Held

288,344

+112.3% QoQ

Ownership

0.525%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,649,670,055 across 35 Medical Devices names. LIVN ranks #15 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BSX	Boston Scientific Corp	13,891,668	$871,702,167
2	ABT	Abbott Laboratories	5,522,222	$566,966,532
3	SYK	Stryker Corp	1,555,638	$511,167,090
4	MDT	Medtronic plc	4,659,425	$403,739,176
5	PODD	Insulet Corp	1,229,928	$258,088,091
6	DXCM	Dexcom Inc	2,545,103	$159,832,468
7	EW	Edwards Lifesciences Corp	1,890,859	$151,419,988
8	PEN	Penumbra Inc	400,160	$131,400,539

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$18,327,144	288,344	+112.3%	Shares	Defined	2026-05-14
2025-06-30	$6,114,796	135,824	+645.3%	Shares	Defined	2025-08-13
2025-03-31	$715,799	18,223	-70.6%	Shares	Defined	2025-05-14
2023-03-31	$2,702,134	62,004	+19.9%	Shares	Defined	2023-05-15
2022-12-31	$2,873,250	51,733	+364.4%	Shares	Defined	2023-02-14
2022-09-30	$565,527	11,139	-83.6%	Shares	Defined	2022-11-14
2022-03-31	$5,543,737	67,747	-62.9%	Shares	Defined	2022-05-13
2021-12-31	$15,958,860	182,533	-38.4%	Shares	Defined	2022-02-14
2021-09-30	$23,455,286	296,190	-5.0%	Shares	Defined	2021-11-12
2021-06-30	$26,213,974	311,663	+3380.3%	Shares	Defined	2021-08-13
2021-03-31	$660,252	8,955	-96.3%	Shares	Defined	2021-05-14
2020-06-30	$11,591,099	240,829	+1041.4%	Shares	Defined	2020-08-12
2020-03-31	$954,775	21,100	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.